FDA Approves New Kyprolis® (Carfilzomib) Combination Therapy For The Treatment Of Patients With Relapsed Or Refractory Multiple Myeloma
FDA granted approval for Halaven (eribulin mesylate) Injection for the treatment of patients with unresectable or metastatic liposarcoma
American Society of Clinical Oncology (ASCO) Clinical Practice Guideline Recommends Use of Prosigna (PAM50) for Guiding Treatment Decisions in Early Stage Breast Cancer Patients
NEW Drugs AND EXPANDED INDICATIONS
Below are postings for new drugs and indications you should be aware of. Please refer to the links below for announcements and details.